CONGENICA
LIVE

Serial Number

79294659

Owner

Congenica Ltd

Attorney

Frank S. Benjamin

Filing Date

Jan 17, 2020

Add to watchlist:

No watchlists yet
View on USPTO

CONGENICA Trademark

Serial Number: 79294659 • Registration: 6458289

CONGENICA is a trademark filed by Congenica Ltd on January 17, 2020. The trademark is classified under Class 9 (Computers & Electronics), Class 38 (Telecommunications), Class 42 (Computer & Scientific), Class 35 (Advertising & Business). The application is currently registered and active.

Owner Contact Info

Congenica Ltd (2 trademarks)

Wellcome Trust Genome Campus,

Entity Type: 99

Trademark Details

Filing Date

January 17, 2020

Registration Date

August 24, 2021

Published for Opposition

June 8, 2021

Goods & Services

Downloadable computer software for database management, genome sequencing, annotation, disease prediction, interpretation and reporting, medical diagnosis and treatments, drug development, discovery and research; downloadable computer platform software for database management, genome sequencing, annotation, disease prediction interpretation and reporting, medical diagnosis and treatments, drug development, discovery and research; downloadable computer database software for database management, genome sequencing, annotation, disease prediction, interpretation and reporting, medical diagnosis and treatments, drug development, discovery and research; downloadable computer software for data analysis and reporting; downloadable computer software for genome sequencing, annotation, disease prediction, interpretation and reporting; downloadable computer software for potential patient identification and medical diagnosis; downloadable computer software for drug discovery and research; downloadable computer software for research and medical purposes; electronic computer databases in the fields of life sciences, medicine, healthcare, genome sequencing, annotation, disease prediction, interpretation and reporting, medical diagnosis and treatments and drug development, discovery and research, treatment of disease recorded on computer media; computer database servers; downloadable computer software for database management; downloadable computer software for creating searchable databases of information and data; downloadable electronic publications in the nature of white papers, articles, magazines and brochures in the field of life sciences, medicine and healthcare downloadable from the Internet

Providing access to computer databases; arranging access to computer databases in the nature of providing access to the databases; operation of computer networks for accessing and sharing data, namely, transmission and distribution of data via a global computer network; information, advisory and consultancy services in relation to all of the aforesaid

Database management; computer database management; database management and database management services in the nature of reporting services information and details from the database; computerised database management services; data management services, namely, collecting and managing data relating to genome sequencing, disease prediction, medical diagnosis and drug development, discovery and treatment; data processing management; compilation of data and information in computer databases; data processing and analysis services; information, advisory and consultancy services in relation to all of the aforesaid

Scientific and technological services, namely, research and design in the field of inherited and acquired genetic disorders, common disorders and disease; scientific research and development services; design and development of databases; design and development of computer databases; database design and development services; computer database design and development services; research and development in the field of genomics; laboratory analysis, namely, genome interpretation and DNA sequencing services; software as a service services featuring software for interpreting inherited and acquired genetic disorders, common disorders and disease; providing software as a service services featuring software for genome sequencing, annotation, interpretation and reporting; providing computer software platforms as a service featuring software for genome sequencing, annotation, interpretation and reporting; providing software as a service featuring software for drug discovery and research; providing software as a service featuring software for potential patient identification and medical diagnosis; providing software as a service featuring software for research and medical purposes; installation, updating and maintenance of computer software; information, advisory and consultancy services in relation to all of the aforesaid

Filing History

TEAS CHANGE OF CORRESPONDENCE RECEIVED
Jun 29, 2022 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Jun 29, 2022 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Jun 29, 2022 REAP
FINAL DECISION TRANSACTION PROCESSED BY IB
Feb 28, 2022 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Feb 3, 2022 FICS
FINAL DISPOSITION PROCESSED
Feb 3, 2022 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Nov 24, 2021 FICR
REGISTERED-PRINCIPAL REGISTER
Aug 24, 2021 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jun 8, 2021 NPUB
PUBLISHED FOR OPPOSITION
Jun 8, 2021 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
May 19, 2021 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
May 5, 2021 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
May 4, 2021 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
May 3, 2021 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
May 3, 2021 TROA
REFUSAL PROCESSED BY IB
Nov 22, 2020 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Nov 2, 2020 RFCS
REFUSAL PROCESSED BY MPU
Nov 2, 2020 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Oct 10, 2020 RFCR
NON-FINAL ACTION WRITTEN
Oct 9, 2020 CNRT
NEW REPRESENTATIVE AT IB RECEIVED
Oct 9, 2020 NREP
APPLICATION FILING RECEIPT MAILED
Oct 9, 2020 MAFR
ASSIGNED TO EXAMINER
Oct 5, 2020 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Oct 5, 2020 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Oct 1, 2020 REPR